Kibum Kim

About

"Pharmacoeconomics and outcomes research" is the area to see the economic/humanistic/clinical impact of drug usage for a variety of stakeholders including patients, payers, and governmental agencies. As population continues to age and the prevalence of chronic conditions continues to increase, population-level outcome evaluation will take a center stage of drug usage and health policy. With a good understanding in from basic science to clinical science, impacts of a healthcare intervention can be analyzed from not only researcher's perspective but also clinician's viewpoints.

Experience

• University of Illinois Chicago (Full-time · 4 yrs 11 mos)
  • Co-Director of UIC/Takeda HEOR Fellowship
    Jul 2023 - Present · 3 yrs

  • Director of Graduate Studies
    Aug 2022 - Present · 3 yrs 11 mos

  • Assistant Professor
    Aug 2021 - Present · 4 yrs 11 mos

• Executive Consultant at KB HEOR
  Dec 2021 - Present · 4 yrs 7 mos

• University of Utah (10 yrs)
  • Adjunct Assistant Professor
    Aug 2021 - Present · 4 yrs 11 mos

  • Research Assistant Professor
    Jul 2018 - Aug 2021 · 3 yrs 2 mos

  • Senior Research Analyst
    Jul 2016 - Jun 2018 · 2 yrs

• University of Illinois at Chicago (5 yrs)
  • Doctoral Candidate
    Nov 2013 - Jul 2016 · 2 yrs 9 mos

  • Teaching Assistant
    Aug 2011 - May 2016 · 4 yrs 10 mos

    Leading Statistiacs Recitations Tutoring Handouts and lecture material preparations Answering for PharmD students' questions about their courses

  • Research Assistant
    Aug 2013 - Jan 2014 · 6 mos

    Retrospective data analysis Case control study Descriptive statistics Regression analysis Data handling in SAS

• Global Outcomes Research Intern at AbbVie
  Jun 2014 - Aug 2014 · 3 mos

  Systematic review Cost Effectiveness studies using decision model Cost of Illness Study - Study design and pilot analysis using claims data